Scaling Legends
Novo Nordisk is investing $4.1 billion in a 1.4-million-square-foot, 10-building manufacturing expansion in Clayton, North Carolina to ramp Ozempic and Wegovy production — and BE&K Building Group just landed the build as Design-Builder and Agency Construction Manager across a 56-acre campus. We break down why life-sciences construction is the new megaproject gold rush, how the design-build delivery model changes who wins subcontracts, and how mid-market contractors can position for phased 2027-2
233 episodes
Comments
0Be the first to comment
Sign up now and become a member of the Scaling Legends community!